Loading...
•
Sep 30, 2023
GoHealth Q3 2023 Earnings Report
GoHealth's financial performance remained relatively stable with a slight revenue decrease, while submissions increased significantly. Net loss and Adjusted EBITDA improved, indicating progress towards profitability.
Key Takeaways
GoHealth reported a slight decrease in net revenues for Q3 2023, but saw a significant increase in submissions. The company's net loss and Adjusted EBITDA improved compared to the prior year period. GoHealth is focused on its Encompass solution and operational excellence to drive future growth and profitability.
Net revenues for Q3 2023 were $132.0 million, slightly down from $133.1 million in the prior year period.
Submissions increased by 31% to 161,550 in Q3 2023, compared to 122,964 in the prior year period.
Net loss for Q3 2023 improved to $56.2 million, compared to $74.7 million in the prior year period.
Adjusted EBITDA for Q3 2023 improved to negative $11.5 million, compared to negative $14.3 million in the prior year period.
Forward Guidance
GoHealth anticipates sustained growth and value delivery to shareholders, focusing on the Encompass model and operational excellence for future quarters.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...